Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders

Journal of Neuroimmunology

Volumn 213, Issue 1-2, 2009, Pages 47-59

  Eggert, Dawn ^a   Dash, Prasanta K ^a   Serradji, Nawal ^b   Dong, Chang Zhi ^b   Clayette, Pascal ^c   Heymans, Francoise ^b   Dou, Huanyu ^a   Gorantla, Santhi ^a   Gelbard, Harris A ^d   Poluektova, Larisa ^a   Gendelman, Howard E ^a,e  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Human immunodeficiency virus; Multinucleated giant cell; Nuclear factor kappa beta; Platelet activating factor; PMS 601; Proline rich tyrosine kinase 2

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PMS 601; PROTEIN P50; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DRUG SCREENING; FEMALE; GIANT CELL; GLIOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MONOCYTE; MOUSE; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCID MOUSE; VIRUS ENCEPHALITIS;

AIDS DEMENTIA COMPLEX; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; CELL DEATH; CELLS, CULTURED; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FOCAL ADHESION KINASE 2; GIANT CELLS; GLIOSIS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, SCID; MICROGLIA; MONOCYTES; NF-KAPPA B; PIPERAZINES; PLATELET ACTIVATING FACTOR;

EID: 68149166882     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.06.002     Document Type: Article

References (102)

1. Bailer R.T., Lee B., and Montaner L.J. IL-13 and TNF-alpha inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5, CXCR4 and post-entry viral gene expression. Eur. J. Immunol. 30 (2000) 1340-1349
2. Baruzzi A., Caveggion E., and Berton G. Regulation of phagocyte migration and recruitment by Src-family kinases. Cell. Mol. Life Sci. 65 (2008) 2175-2190
3. Bate C., Kempster S., and Williams A. Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death. Neuropharmacology 51 (2006) 173-181
4. Bate C., Kempster S., and Williams A. Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells. Neuropharmacology 50 (2006) 229-237
5. Belanger C., Elimam H., Lefebvre J., Borgeat P., and Marleau S. Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats. Immunology 124 (2008) 295-303
6. Bhaskaran K., Mussini C., Antinori A., Walker A.S., Dorrucci M., Sabin C., Phillips A., and Porter K. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann. Neurol. 63 (2008) 213-221
7. Boisse L., Gill M.J., and Power C. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol. Clin. 26 (2008) 799-819 x
8. Boyce J.A. Eicosanoids in asthma, allergic inflammation, and host defense. Curr. Mol. Med. 8 (2008) 335-349
9. Buscemi L., Ramonet D., and Geiger J.D. Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol. Dis. 26 (2007) 661-670
10. Chakraborty P. G-protein-mediated signaling and its control in macrophages and mammalian cells. Crit. Rev. Microbiol. 27 (2001) 1-8
11. Charpentier C., Dwyer D.E., Mammano F., Lecossier D., Clavel F., and Hance A.J. Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors. J. Virol. 78 (2004) 4234-4247
12. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess Jr. J.W., Sowder II R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., and Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 80 (2006) 9039-9052
13. Cuschieri J., Gourlay D., Bulger E., Garcia I., Jelacic S., and Maier R.V. Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. Surgery 132 (2002) 157-166
14. Deeks S.G., Hoh R., Neilands T.B., Liegler T., Aweeka F., Petropoulos C.J., Grant R.M., and Martin J.N. Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection. J. Infect. Dis. 192 (2005) 1537-1544
15. Del Sorbo L., DeMartino A., Biancone L., Bussolati B., Conaldi P.G., Toniolo A., and Camussi G. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat. Eur. J. Immunol. 29 (1999) 1513-1521
16. Del Sorbo L., Arese M., Giraudo E., Tizzani M., Biancone L., Bussolino F., and Camussi G. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. Eur. J. Immunol. 31 (2001) 376-383
17. Dent G., Munoz N.M., Zhu X., Ruhlmann E., Magnussen H., Leff A.R., and Rabe K.F. Involvement of protein tyrosine kinases in activation of human eosinophils by platelet-activating factor. Immunology 100 (2000) 231-237
18. Devadas K., Hardegen N.J., Wahl L.M., Hewlett I.K., Clouse K.A., Yamada K.M., and Dhawan S. Mechanisms for macrophage-mediated HIV-1 induction. J. Immunol. 173 (2004) 6735-6744
19. Dhillon N., Zhu X., Peng F., Yao H., Williams R., Qiu J., Callen S., Ladner A.O., and Buch S. Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-gamma in macrophages. J. Neurovirol. 14 (2008) 196-204
20. Duong L.T., and Rodan G.A. PYK2 is an adhesion kinase in macrophages, localized in podosomes and activated by beta(2)-integrin ligation. Cell Motil. Cytoskelet. 47 (2000) 174-188
21. 2+ entry resulting in apoptosis. J. Neurochem. 104 (2008) 1177-1189
22. + T lymphocytes and macrophages. J. Virol. 77 (2003) 2539-2549
23. Friedman M.S., Long M.W., and Hankenson K.D. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J. Cell. Biochem. 98 (2006) 538-554
24. Gelbard H.A., Nottet H.S., Swindells S., Jett M., Dzenko K.A., Genis P., White R., Wang L., Choi Y.B., Zhang D., et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68 (1994) 4628-4635
25. Gendelman H.E., Orenstein J.M., Martin M.A., Ferrua C., Mitra R., Phipps T., Wahl L.A., Lane H.C., Fauci A.S., Burke D.S., et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167 (1988) 1428-1441
26. Gismondi A., Bisogno L., Mainiero F., Palmieri G., Piccoli M., Frati L., and Santoni A. Proline-rich tyrosine kinase-2 activation by beta 1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J. Immunol. 159 (1997) 4729-4736
27. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
28. Helming L., Winter J., and Gordon S. The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion. J. Cell Sci. 122 (2009) 453-459
29. Herbein G., and Khan K.A. Is HIV infection a TNF receptor signalling-driven disease?. Trends. Immunol. 29 (2008) 61-67
30. Herbein G., Varin A., Larbi A., Fortin C., Mahlknecht U., Fulop T., and Aggarwal B.B. Nef and TNFalpha are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages. Curr. HIV Res. 6 (2008) 117-129
31. Ibarrondo F.J., Choi R., Geng Y.Z., Canon J., Rey O., Baldwin G.C., and Krogstad P. HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. AIDS Res. Hum. Retrovir. 17 (2001) 1489-1500
32. Ichiyama T., Hasegawa M., Hashimoto K., Matsushige T., Hirano R., and Furukawa S. Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages. Int. Arch. Allergy Immunol. 148 (2009) 147-153
33. Janelsins M.C., Mastrangelo M.A., Park K.M., Sudol K.L., Narrow W.C., Oddo S., LaFerla F.M., Callahan L.M., Federoff H.J., and Bowers W.J. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Am. J. Pathol. 173 (2008) 1768-1782
34. Kadiu I., Glanzer J.G., Kipnis J., Gendelman H.E., and Thomas M.P. Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases. Neurotox. Res. 8 (2005) 25-50
35. Kalter D.C., Nakamura M., Turpin J.A., Baca L.M., Hoover D.L., Dieffenbach C., Ralph P., Gendelman H.E., and Meltzer M.S. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J. Immunol. 146 (1991) 298-306
36. Kihara Y., Ishii S., Kita Y., Toda A., Shimada A., and Shimizu T. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. J. Exp. Med. 202 (2005) 853-863
37. Kim J.W., Lee J.E., Kim M.J., Cho E.G., Cho S.G., and Choi E.J. Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). J. Biol. Chem. 278 (2003) 13995-14001
38. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pezeshkpour G.H., Yungbluth M., Janotta F., Aksamit A., Martin M.A., and Fauci A.S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233 (1986) 1089-1093
39. Kovacs A.D., Chakraborty-Sett S., Ramirez S.H., Sniderhan L.F., Williamson A.L., and Maggirwar S.B. Mechanism of NF-kappaB inactivation induced by survival signal withdrawal in cerebellar granule neurons. Eur. J. Neurosci. 20 (2004) 345-352
40. Kwon K.J., Jung Y.S., Lee S.H., Moon C.H., and Baik E.J. Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase. J. Neurosci. Res. 81 (2005) 73-84
41. Lattin J., Zidar D.A., Schroder K., Kellie S., Hume D.A., and Sweet M.J. G-protein-coupled receptor expression, function, and signaling in macrophages. J. Leukoc. Biol. 82 (2007) 16-32
42. Lee C., Tomkowicz B., Freedman B.D., and Collman R.G. HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways. J. Leukoc. Biol. 78 (2005) 1016-1023
43. Leghmari K., Bennasser Y., and Bahraoui E. HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways. Eur. J. Cell. Biol. 87 (2008) 947-962
44. Leghmari K., Bennasser Y., Tkaczuk J., and Bahraoui E. HIV-1 Tat protein induces IL-10 production by an alternative TNF-alpha-independent pathway in monocytes: role of PKC-delta and p38 MAP kinase. Cell. Immunol. 253 (2008) 45-53
45. Leghmari K., Contreras X., Moureau C., and Bahraoui E. HIV-1 Tat protein induces TNF-alpha and IL-10 production by human macrophages: differential implication of PKC-betaII and -delta isozymes and MAP kinases ERK1/2 and p38. Cell. Immunol. 254 (2008) 46-55
46. Letendre S., Ances B., Gibson S., and Ellis R.J. Neurologic complications of HIV disease and their treatment. Top HIV Med. 15 (2007) 32-39
47. Li X., Hunter D., Morris J., Haskill J.S., and Earp H.S. A calcium-dependent tyrosine kinase splice variant in human monocytes. Activation by a two-stage process involving adherence and a subsequent intracellular signal. J. Biol. Chem. 273 (1998) 9361-9364
48. Liew F.Y., Xu D., Brint E.K., and O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5 (2005) 446-458
49. Lima R.G., Moreira L., Paes-Leme J., Barreto-de-Souza V., Castro-Faria-Neto H.C., Bozza P.T., and Bou-Habib D.C. Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor. AIDS Res. Hum. Retrovir. 22 (2006) 763-769
50. Limoges J., Poluektova L., Ratanasuwan W., Rasmussen J., Zelivyanskaya M., McClernon D.R., Lanier E.R., Gendelman H.E., and Persidsky Y. The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis. Virology 281 (2001) 21-34
51. Lipton S.A. Neuronal injury associated with HIV-1: approaches to treatment. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 159-177
52. + T cells generates a diversity of syncytia varying in total number, size and cellular content. Virus Res. 123 (2007) 138-146
53. Maestre C., Zarco P., Gomez-Guerrero C., Gonzalez E., Herrero-Beaumont G., Braquet M., and Egido J. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response. J. Lipid Mediat. 2 (1990) S151-S159 Suppl
54. Martin M., Rehani K., Jope R.S., and Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6 (2005) 777-784
55. Martin M., Serradji N., Dereuddre-Bosquet N., Le Pavec G., Fichet G., Lamouri A., Heymans F., Godfroid J.J., Clayette P., and Dormont D. PMS-601, a new platelet-activating factor receptor antagonist that inhibits human immunodeficiency virus replication and potentiates zidovudine activity in macrophages. Antimicrob. Agents Chemother. 44 (2000) 3150-3154
56. Masliah E., Ge N., Achim C.L., DeTeresa R., and Wiley C.A. Patterns of neurodegeneration in HIV encephalitis. J. Neuro-AIDS 1 (1996) 161-173
57. Matucci A., Rossolillo P., Baroni M., Siccardi A.G., Beretta A., and Zipeto D. HLA-C increases HIV-1 infectivity and is associated with gp120. Retrovirology 5 (2008) 68
58. Mellgren A., Price R.W., Hagberg L., Rosengren L., Brew B.J., and Gisslen M. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology 69 (2007) 1536-1541
59. Mitra S.K., Hanson D.A., and Schlaepfer D.D. Focal adhesion kinase: in command and control of cell motility. Nat. Rev., Mol. Cell Biol. 6 (2005) 56-68
60. Montecucco F., Steffens S., Burger F., Da Costa A., Bianchi G., Bertolotto M., Mach F., Dallegri F., and Ottonello L. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways. Cell. Signal. 20 (2008) 557-568
61. Muller-Ladner U., Gay R.E., and Gay S. Role of nuclear factor kappaB in synovial inflammation. Curr. Rheumatol. Rep. 4 (2002) 201-207
62. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
63. Navia B.A., Cho E.S., Petito C.K., and Price R.W. The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 19 (1986) 525-535
64. Okamoto M., Wang X., and Baba M. HIV-1-infected macrophages induce astrogliosis by SDF-1alpha and matrix metalloproteinases. Biochem. Biophys. Res. Commun. 336 (2005) 1214-1220
65. Pandey P., Avraham S., Kumar S., Nakazawa A., Place A., Ghanem L., Rana A., Kumar V., Majumder P.K., Avraham H., Davis R.J., and Kharbanda S. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. J. Biol. Chem. 274 (1999) 10140-10144
66. Perry S.W., Hamilton J.A., Tjoelker L.W., Dbaibo G., Dzenko K.A., Epstein L.G., Hannun Y., Whittaker J.S., Dewhurst S., and Gelbard H.A. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. J Biol Chem 273 (1998) 17660-17664
67. Persidsky Y., Limoges J., McComb R., Bock P., Baldwin T., Tyor W., Patil A., Nottet H.S., Epstein L., Gelbard H., Flanagan E., Reinhard J., Pirruccello S.J., and Gendelman H.E. Human immunodeficiency virus encephalitis in SCID mice. Am. J. Pathol. 149 (1996) 1027-1053
68. Persidsky Y., Buttini M., Limoges J., Bock P., and Gendelman H.E. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J. Neurovirology 3 (1997) 401-416
69. Persidsky Y., Limoges J., Rasmussen J., Zheng J., Gearing A., and Gendelman H.E. Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. J. Neuroimmunol. 114 (2001) 57-68
70. Poluektova L., Gorantla S., Faraci J., Birusingh K., Dou H., and Gendelman H.E. Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. J. Immunol. 172 (2004) 7610-7617
71. Rey A., M'Rini C., Sozzani P., Lamboeuf Y., Beraud M., Caput D., Ferrara P., and Pipy B. IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages. Biochim. Biophys. Acta. 1393 (1998) 244-252
72. Rodriguez-Fernandez J.L., Gomez M., Luque A., Hogg N., Sanchez-Madrid F., and Cabanas C. The interaction of activated integrin lymphocyte function-associated antigen 1 with ligand intercellular adhesion molecule 1 induces activation and redistribution of focal adhesion kinase and proline-rich tyrosine kinase 2 in T lymphocytes. Mol. Biol. Cell. 10 (1999) 1891-1907
73. Roquebert B., Malet I., Wirden M., Tubiana R., Valantin M.A., Simon A., Katlama C., Peytavin G., Calvez V., and Marcelin A.G. Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors. Aids 20 (2006) 287-289
74. Rumsey L.M., Teague R.M., Benedict S.H., and Chan M.A. MIP-1alpha induces activation of phosphatidylinositol-3 kinase that associates with Pyk-2 and is necessary for B-cell migration. Exp. Cell Res. 268 (2001) 77-83
75. Ryan S.D., Harris C.S., Carswell C.L., Baenziger J.E., and Bennett S.A. Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons. J. Lipid Res. 49 (2008) 2250-2258
76. Sang N., Zhang J., Marcheselli V., Bazan N.G., and Chen C. Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J. Neurosci. 25 (2005) 9858-9870
77. Schaloske R.H., Provins J.W., Kessen U.A., and Dennis E.A. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages. Biochim. Biophys. Acta. 1687 (2005) 64-75
78. Schuhmann M.U., Mokhtarzadeh M., Stichtenoth D.O., Skardelly M., Klinge P.M., Gutzki F.M., Samii M., and Brinker T. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. Neurol. Res. 25 (2003) 481-491
79. Serradji N., Bensaid O., Martin M., Kan E., Dereuddre-Bosquet N., Redeuilh C., Huet J., Heymans F., Lamouri A., Clayette P., Dong C.Z., Dormont D., and Godfroid J.J. Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication. J. Med. Chem. 43 (2000) 2149-2154
80. Serradji N., Martin M., Bensaid O., Cisternino S., Rousselle C., Dereuddre-Bosquet N., Huet J., Redeuilh C., Lamouri A., Dong C.Z., Clayette P., Scherrmann J.M., Dormont D., and Heymans F. Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity. J. Med. Chem. 47 (2004) 6410-6419
81. Smith D.G., Guillemin G.J., Pemberton L., Kerr S., Nath A., Smythe G.A., and Brew B.J. Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J. Neurovirol. 7 (2001) 56-60
82. Sneddon A.A., McLeod E., Wahle K.W., and Arthur J.R. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. Biochim. Biophys. Acta. 1761 (2006) 793-801
83. Steain M.C., Wang B., and Saksena N.K. The possible contribution of HIV-1-induced syncytia to the generation of intersubtype recombinants in vitro. Aids 22 (2008) 1009-1017
84. Stone T.W., and Behan W.M. Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist. J. Neurosci. Res. 85 (2007) 1077-1085
85. Tokiwa G., Dikic I., Lev S., and Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science 273 (1996) 792-794
86. Tong N., Sanchez J.F., Maggirwar S.B., Ramirez S.H., Guo H., Dewhurst S., and Gelbard H.A. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur. J. Neurosci. 13 (2001) 1913-1922
87. Tozser J. HIV inhibitors: problems and reality. Ann. N.Y. Acad. Sci. 946 (2001) 145-159
88. Tozzi V., Balestra P., Bellagamba R., Corpolongo A., Salvatori M.F., Visco-Comandini U., Vlassi C., Giulianelli M., Galgani S., Antinori A., and Narciso P. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J. Acquir. Immune Defic. Syndr. 45 (2007) 174-182
89. 2+ events and cytoskeletal reorganization. Trends Immunol. 22 (2001) 17-20
90. Tyor W.R., Power C., Gendelman H.E., and Markham R.B. A model of human immunodeficiency virus encephalitis in scid mice. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8658-8662
91. Versteeg H.H., Nijhuis E., van den Brink G.R., Evertzen M., Pynaert G.N., van Deventer S.J., Coffer P.J., and Peppelenbosch M.P. A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem. J. 350 Pt. 3 (2000) 717-722
92. Vilimek D., and Duronio V. Cytokine-stimulated phosphorylation of GSK-3 is primarily dependent upon PKCs, not PKB. Biochem. Cell. Biol. 84 (2006) 20-29
93. Villa G., Solida A., Moro E., Tavolozza M., Antinori A., De Luca A., Murri R., and Tamburrini E. Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. Eur. Neurol. 36 (1996) 125-133
94. Viviani B., Gardoni F., Bartesaghi S., Corsini E., Facchi A., Galli C.L., Di Luca M., and Marinovich M. Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J. Biol. Chem. 281 (2006) 30212-30222
95. Warrilow D., Gardner J., Darnell G.A., Suhrbier A., and Harrich D. HIV type 1 inhibition by protein kinase C modulatory compounds. AIDS Res. Hum. Retrovir. 22 (2006) 854-864
96. Wells C.A., Ravasi T., and Hume D.A. Inflammation suppressor genes: please switch out all the lights. J. Leukoc. Biol. 78 (2005) 9-13
97. Wolf D., Giese S.I., Witte V., Krautkramer E., Trapp S., Sass G., Haller C., Blume K., Fackler O.T., and Baur A.S. Novel (n)PKC kinases phosphorylate Nef for increased HIV transcription, replication and perinuclear targeting. Virology 370 (2008) 45-54
98. Worthylake R.A., and Burridge K. RhoA and ROCK promote migration by limiting membrane protrusions. J. Biol. Chem. 278 (2003) 13578-13584
99. Xiong H., Boyle J., Winkelbauer M., Gorantla S., Zheng J., Ghorpade A., Persidsky Y., Carlson K.A., and Gendelman H.E. Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J. Neurosci. Res. 71 (2003) 600-607
100. Zheng J., Thylin M.R., Ghorpade A., Xiong H., Persidsky Y., Cotter R., Niemann D., Che M., Zeng Y.C., Gelbard H.A., Shepard R.B., Swartz J.M., and Gendelman H.E. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98 (1999) 185-200
101. Zhu X.W., and Friedland J.S. Multinucleate giant cells and the control of chemokine secretion in response to Mycobacterium tuberculosis. Clin. Immunol. 120 (2006) 10-20
102. Zhu X., Boetticher E., Wang L., Duan Y., Learoyd J., and Leff A.R. Proline-rich tyrosine kinase 2 regulates spreading and migration of eosinophils after beta2-integrin adhesion. Am. J. Respir. Cell Mol. Biol. 39 (2008) 263-269